These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 34233082)

  • 1. Deciphering the detailed structure-activity relationship of coumarins as Monoamine oxidase enzyme inhibitors-An updated review.
    Koyiparambath VP; Prayaga Rajappan K; Rangarajan TM; Al-Sehemi AG; Pannipara M; Bhaskar V; Nair AS; Sudevan ST; Kumar S; Mathew B
    Chem Biol Drug Des; 2021 Oct; 98(4):655-673. PubMed ID: 34233082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comprehensive review on synthesis and designing aspects of coumarin derivatives as monoamine oxidase inhibitors for depression and Alzheimer's disease.
    Patil PO; Bari SB; Firke SD; Deshmukh PK; Donda ST; Patil DA
    Bioorg Med Chem; 2013 May; 21(9):2434-50. PubMed ID: 23517722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Focusing on new monoamine oxidase inhibitors: differently substituted coumarins as an interesting scaffold.
    Matos MJ; Viña D; Vazquez-Rodriguez S; Uriarte E; Santana L
    Curr Top Med Chem; 2012; 12(20):2210-39. PubMed ID: 23231397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3-Coumaranone derivatives as inhibitors of monoamine oxidase.
    Van Dyk AS; Petzer JP; Petzer A; Legoabe LJ
    Drug Des Devel Ther; 2015; 9():5479-89. PubMed ID: 26491258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Comprehensive Review of Monoamine Oxidase-A Inhibitors in their Syntheses and Potencies.
    Rehuman NA; Mathew B; Jat RK; Nicolotti O; Kim H
    Comb Chem High Throughput Screen; 2020; 23(9):898-914. PubMed ID: 32342809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of a novel class of potent coumarin monoamine oxidase B inhibitors: development and biopharmacological profiling of 7-[(3-chlorobenzyl)oxy]-4-[(methylamino)methyl]-2H-chromen-2-one methanesulfonate (NW-1772) as a highly potent, selective, reversible, and orally active monoamine oxidase B inhibitor.
    Pisani L; Muncipinto G; Miscioscia TF; Nicolotti O; Leonetti F; Catto M; Caccia C; Salvati P; Soto-Otero R; Mendez-Alvarez E; Passeleu C; Carotti A
    J Med Chem; 2009 Nov; 52(21):6685-706. PubMed ID: 19810674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and structure-activity relationship study of novel 3-heteroarylcoumarins based on pyridazine scaffold as selective MAO-B inhibitors.
    Costas-Lago MC; Besada P; Rodríguez-Enríquez F; Viña D; Vilar S; Uriarte E; Borges F; Terán C
    Eur J Med Chem; 2017 Oct; 139():1-11. PubMed ID: 28797881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural Exploration of Synthetic Chromones as Selective MAO-B Inhibitors: A Mini Review.
    Mathew B; Mathew GE; Petzer JP; Petzer A
    Comb Chem High Throughput Screen; 2017; 20(6):522-532. PubMed ID: 28245770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Privileged scaffolds as MAO inhibitors: Retrospect and prospects.
    Tripathi AC; Upadhyay S; Paliwal S; Saraf SK
    Eur J Med Chem; 2018 Feb; 145():445-497. PubMed ID: 29335210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel monoamine oxidase inhibitors based on the privileged 2-imidazoline molecular framework.
    Shetnev A; Osipyan A; Baykov S; Sapegin A; Chirkova Z; Korsakov M; Petzer A; Engelbrecht I; Petzer JP
    Bioorg Med Chem Lett; 2019 Jan; 29(1):40-46. PubMed ID: 30455149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual-target anti-Alzheimer's disease agents with both iron ion chelating and monoamine oxidase-B inhibitory activity.
    Mi Z; Gan B; Yu S; Guo J; Zhang C; Jiang X; Zhou T; Su J; Bai R; Xie Y
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1489-1497. PubMed ID: 31416364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, human monoamine oxidase inhibitory activity and molecular docking studies of 3-heteroarylcoumarin derivatives.
    Delogu G; Picciau C; Ferino G; Quezada E; Podda G; Uriarte E; Viña D
    Eur J Med Chem; 2011 Apr; 46(4):1147-52. PubMed ID: 21316817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural and synthetic geiparvarins are strong and selective MAO-B inhibitors. Synthesis and SAR studies.
    Carotti A; Carrieri A; Chimichi S; Boccalini M; Cosimelli B; Gnerre C; Carotti A; Carrupt PA; Testa B
    Bioorg Med Chem Lett; 2002 Dec; 12(24):3551-5. PubMed ID: 12443774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, pharmacological study and docking calculations of new benzo[f]coumarin derivatives as dual inhibitors of enzymatic systems involved in neurodegenerative diseases.
    Matos MJ; Janeiro P; González Franco RM; Vilar S; Tatonetti NP; Santana L; Uriarte E; Borges F; Fontenla JA; Viña D
    Future Med Chem; 2014 Mar; 6(4):371-83. PubMed ID: 24635520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel reversible monoamine oxidase A inhibitors: highly potent and selective 3-(1H-pyrrol-3-yl)-2-oxazolidinones.
    Valente S; Tomassi S; Tempera G; Saccoccio S; Agostinelli E; Mai A
    J Med Chem; 2011 Dec; 54(23):8228-32. PubMed ID: 22017497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of new 7-oxycoumarin derivatives as potent and selective monoamine oxidase A inhibitors.
    Abdelhafez OM; Amin KM; Ali HI; Abdalla MM; Batran RZ
    J Med Chem; 2012 Dec; 55(23):10424-36. PubMed ID: 23153282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coumarin derivatives as inhibitors of d-amino acid oxidase and monoamine oxidase.
    Bester E; Petzer A; Petzer JP
    Bioorg Chem; 2022 Jun; 123():105791. PubMed ID: 35413582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of 6-methyl-3-phenylcoumarins as potent and selective MAO-B inhibitors.
    Matos MJ; Viña D; Picciau C; Orallo F; Santana L; Uriarte E
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5053-5. PubMed ID: 19628387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and selective human monoamine oxidase inhibition of 3-carbonyl, 3-acyl, and 3-carboxyhydrazido coumarin derivatives.
    Secci D; Carradori S; Bolasco A; Chimenti P; Yáñez M; Ortuso F; Alcaro S
    Eur J Med Chem; 2011 Oct; 46(10):4846-52. PubMed ID: 21872365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alkynyl-coumarinyl ethers as MAO-B inhibitors.
    Mertens MD; Hinz S; Müller CE; Gütschow M
    Bioorg Med Chem; 2014 Mar; 22(6):1916-28. PubMed ID: 24560738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.